Article

miamiherald.com on 2021-09-28 17:32

Drugs used by some people with Type 2 diabetes may reduce their risks of severe COVID

GLP-1R agonists, drugs used to treat Type 2 diabetes, may reduce risks of severe COVID-19 such as hospitalization and death for people with the condition.

Related news